Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-18 Lazar David E. Chief Executive Officer Other disposition · Convertible Loan −368,614 0
2025-11-24 Lazar David E. Chief Executive Officer Grant or award · Series AA Convertible Preferred Stock +900,000 900,000
2025-10-23 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −967 $0.82 $793 28,906
2025-10-23 Iwicki Mark T Director Sale −154,894 $0.81 $125K 103,540
2025-10-22 Kharabi Darius CHIEF BUSINESS OFFICER Sale −20,806 $0.83 $17K 41,760
2025-10-22 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −32,230 $0.83 $27K 29,873
2025-10-22 Bazemore Todd Director Sale −47,768 $0.83 $40K 35,932
2025-10-22 Brazzell Romulus K SEE REMARKS Sale −46,748 $0.83 $39K 35,952
2025-10-01 BAKER BROS. ADVISORS LP Former 10% owner Sale −50,640 $1.38 $70K 46,480
2025-10-01 BAKER BROS. ADVISORS LP Former 10% owner Sale −462,967 $1.38 $641K 425,006
2025-09-30 BAKER BROS. ADVISORS LP Former 10% owner Sale −21,376 $1.60 $34K 97,120
2025-09-30 BAKER BROS. ADVISORS LP Former 10% owner Sale −195,425 $1.60 $312K 887,973
2025-08-29 Bazemore Todd SEE REMARKS Grant or award · Stock Option (right to buy) +180,000 180,000
2025-06-24 Kharabi Darius CHIEF BUSINESS OFFICER Sale −4,511 $4.01 $18K 62,566
2025-06-24 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −3,631 $4.01 $15K 62,100
2025-06-24 Bazemore Todd SEE REMARKS Sale −4,058 $4.01 $16K 83,699
2025-06-24 Brazzell Romulus K SEE REMARKS Sale −5,251 $4.01 $21K 82,698
2025-06-24 Iwicki Mark T Director Sale −13,227 $4.01 $53K 258,433
2025-06-15 Rosen Howard B Director Grant or award +2,450 16,240
2025-06-15 Rosen Howard B Director Grant or award · Stock Option (right to buy) +5,450 5,450

Page 1 of 12 · 236 trades